The Tennessee Department of Health has said it has withdrawn information from its website that had identified 74 facilities in the state as thought to have received suspect medication from the New England Compounding Center.
The TDH said it is waiting for corrected information.
The department had gotten its list from the Food and Drug Administration, which posted on its website that there had been technical problems and incorrect data in connection with the list. The FDA said it is redoing the list and will repost it on its website when it is sure of the information.
The TDH said it anticipates there will be fewer state facilities shown once the new list comes out and that it will quickly notify any state facilities that might be identified in connection with the recall.
The FDA and the Centers for Disease Control and Prevention have some concerns that some material from the New England pharmacy used in eye and heart surgeries may have contributed to health problems in some patients. However, a news release said that no patients in Tennessee have been identified as having issues caused by the products.